Those pointing fingers at Nvidia (NASDAQ:NVDA) for an “AI bubble” are missing the mark. The real overreach isn’t coming from the company that’s actually constrained by compute resources. Instead, it’s the legion of publicly traded and private companies whose valuations are built on Nvidia’s narrative, even though they don’t possess the hardware, the energy infrastructure, or the distribution channels that bring that narrative to life.The harsh reality is that the biggest danger in AI stocks right now is the ...

Despite fresh regulatory concerns, Nvidia (NASDAQ: NVDA) jumped nearly 2% on Wednesday as analysts lifted their price targets, reinforcing bullish sentiment, with Wedbush reiterating their $230 price target.On Tuesday, concerns were mounting for the AI chipamer following news that Meta (NASDAQ: META) was considering using Google’s Tensor Processing Units in 2027. Today, the pressure rose after Chinese regulators reportedly banned ByteDance, the company most known as the owner of TikTok, from using Nvidia’s ...

Key Takeaways CSIQ expands from modules into global solar plants and advanced energy-storage projects.Canadian Solar's new German storage contract boosts its shift toward grid solutions and services.FSLR grows capacity with new AI-enabled U.S. facilities and added module finishing lines.With the rising demand for solar energy, investors are showing heightened interest in companies positioned at the center of the solar value chain. Two notable players are First Solar (FSLR) and Canadian Solar (CSIQ) . While ...

Bitcoin miner Cipher (Nasdaq: CIFR) announced redemption for all remaining outstanding warrants before December 26, according to a filing issued on Wednesday. Cipher said it will redeem all unexercised warrants at 5:00 p.m. New York time on December 26 for $0.01 per warrant. The redemption was triggered after shares closed at or above $18.00 on 20 trading days within a 30-day period ending November 21. The warrants were originally issued under an agreement signed in October 2020 with Continental Stock Tra ...

特斯拉全球市场表现 - 在欧洲、英国和EFTA地区，10月注册量（作为销售指标）暴跌49%至6,964辆，而其竞争对手中国比亚迪的注册量激增207%至17,470辆[1] - 特斯拉在欧洲电动汽车市场已失去大量份额，且可能难以收复，同时该地区所有主要传统汽车公司均在积极推动电动汽车销售[1] - 在中国市场，10月月度销量降至26,006辆，为三年来的低点，面临数十家本土电动汽车公司的激烈竞争和价格压力[2] - 在美国市场，特斯拉的市场份额从2019年的80%降至今年初的45%，尽管因关税问题暂无中国竞争对手，但传统汽车公司已积极投入电动汽车领域，耗资数百亿美元[3] 公司战略与市场估值 - 全球销量下滑促使公司首席执行官埃隆·马斯克需向市场强调特斯拉是一家专注于机器人技术和人工智能的公司，目标推出首款全自动驾驶汽车和机器人出租车[4] - 特斯拉在自动驾驶汽车业务上面临激烈竞争，主要对手包括Alphabet旗下的Waymo[4] - 尽管4月股价暴跌，但特斯拉今年股价上涨3%，虽低于标普500指数14%的涨幅，公司市值仍高达1.4万亿美元，位列全球第十大上市公司[4]

Finance minister Rachel Reeves said the leak by the government spending watchdog was "deeply disappointing" and a "serious error." ...

服务内容 - 提供针对贵金属矿商的深入研究报告 旨在识别估值偏低且具备短期催化剂的标的以驱动投资组合表现 [1] - 订阅者可获取当前投资组合信息以及实时的买卖信号 [1] - 提供投资组合的入场/出场点位 以及针对黄金和白银矿商的专有情绪指标 [1] 分析师背景 - 分析师Taylor Dart为个人投资者 拥有超过16年的交易经验 [1] - 其研究重点集中于贵金属领域的开发商 生产商以及权利金/流公司 [1]

QUEBEC, QC / ACCESS Newswire / November 26, 2025 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC:NRRWF)(FSE:1RN), a leading provider of mobile and broadband wireless infrastructure, has announced the successful closing of a non-brokered private placement financing, raising gross proceeds of CA$ 300,000 (the "Private Placement"). This was accomplished through the issuance of 13,636,362 units of the Company (each referred to as a "Unit") priced at $0.022 per Unit. ...

Stride, based in Reston, Virginia, provides online and blended education services to schools and school districts across the United States. Accessibility StatementSkip Navigation PHILADELPHIA, Nov. 26, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) ("Stride" or the "Company") on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the ...

BREAKING: Stocks Rise, Extending Rebound Sanofi (SNY) stock dropped Wednesday after French authorities raided the drugmaker's Paris headquarters as part of a tax fraud investigation. The pharma giant, whose biggest product is anti-inflammatory drug Dupixent, confirmed that the investigation is related to a financing arrangement offered by Societe Generale SA, dating back 10 years ago. The mechanism is now under investigation by the French National Financial Prosecutor's Office. Officials visited the company ...